(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(-0.23%) $83.66
(-1.16%) $1.619
(0.10%) $2 349.60
(-0.07%) $27.52
(0.25%) $924.40
(0.35%) $0.935
(0.54%) $11.01
(0.10%) $0.800
(0.00%) $92.17
-1.36% INR 279.75
Live Chart Being Loaded With Signals
Shalby Limited operates multi-specialty hospitals primarily in India. The company offers arthroscopy, arthroplasty, cardiology, cardiothoracic and vascular surgery, cosmetic and aesthetic, dental cosmetic and implant ology, emergency medicine, endocrinology, endoscopy and laparoscopy, ENT surgery, gastroentero surgery, gastroenterology, general medicine and surgery, hair transplant, liver disease and transplant, and hip and knee joint replacement services...
Stats | |
---|---|
Tagesvolumen | 269 841 |
Durchschnittsvolumen | 271 325 |
Marktkapitalisierung | 30.22B |
EPS | INR0 ( 2024-02-12 ) |
Nächstes Ertragsdatum | ( INR0 ) 2024-05-12 |
Last Dividend | INR1.200 ( 2023-08-08 ) |
Next Dividend | INR0 ( N/A ) |
P/E | 36.91 |
ATR14 | INR0.454 (0.16%) |
Volumen Korrelation
Shalby Limited Korrelation
10 Am meisten positiv korreliert |
---|
10 Am meisten negativ korreliert |
---|
Wussten Sie das?
Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).
Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.
Shalby Limited Korrelation - Währung/Rohstoff
Shalby Limited Finanzdaten
Annual | 2022 |
Umsatz: | INR8.05B |
Bruttogewinn: | INR3.70B (45.94 %) |
EPS: | INR6.30 |
FY | 2022 |
Umsatz: | INR8.05B |
Bruttogewinn: | INR3.70B (45.94 %) |
EPS: | INR6.30 |
FY | 2022 |
Umsatz: | INR6.99B |
Bruttogewinn: | INR3.05B (43.58 %) |
EPS: | INR6.46 |
FY | 2021 |
Umsatz: | INR4.31B |
Bruttogewinn: | INR1.81B (42.07 %) |
EPS: | INR4.71 |
Financial Reports:
No articles found.
Shalby Limited Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
INR1.000 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR1.200 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | INR0.500 | 2019-08-16 |
Last Dividend | INR1.200 | 2023-08-08 |
Next Dividend | INR0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 5 | -- |
Total Paid Out | INR4.20 | -- |
Avg. Dividend % Per Year | 0.51% | -- |
Score | 1.9 | -- |
Div. Sustainability Score | 3.43 | |
Div.Growth Potential Score | 4.23 | |
Div. Directional Score | 3.83 | -- |
Year | Amount | Yield |
---|---|---|
2019 | INR0.500 | 0.34% |
2020 | INR0.500 | 0.54% |
2021 | INR1.000 | 0.92% |
2022 | INR1.000 | 0.70% |
2023 | INR1.200 | 0.79% |
2024 | INR0 | 0.00% |
The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
SANDHAR.NS | Dividend Junior | 2023-09-14 | Annually | 7 | 0.66% | |
LXCHEM.NS | Dividend Junior | 2023-07-20 | Annually | 4 | 0.11% | |
GLENMARK.NS | Dividend Junior | 2023-09-18 | Annually | 23 | 0.37% | |
ASIANPAINT.NS | Dividend Junior | 2023-06-09 | Semi-Annually | 23 | 0.43% | |
TINPLATE.NS | Dividend Junior | 2023-08-11 | Annually | 19 | 0.72% | |
PDMJEPAPER.NS | Dividend Junior | 2023-08-03 | Annually | 9 | 0.65% | |
J&KBANK.NS | Dividend Junior | 2023-08-17 | Sporadic | 22 | 0.47% | |
DATAMATICS.NS | Dividend Junior | 2023-09-22 | Annually | 21 | 0.49% | |
SHYAMMETL.NS | Dividend Junior | 2023-06-05 | Semi-Annually | 4 | 0.70% | |
MAXHEALTH.NS | Dividend Junior | 2023-09-08 | Insufficient data to determine frequency | 2 | 0.07% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0916 | 1.500 | 8.17 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0 | 1.200 | 0 | 0 | [0 - 0.3] |
returnOnEquityTTM | 0.0860 | 1.500 | -0.155 | -0.233 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 0 | 0.800 | -5.00 | -4.00 | [1 - 3] |
quickRatioTTM | 0 | 0.800 | -4.71 | -3.76 | [0.8 - 2.5] |
cashRatioTTM | 0 | 1.500 | -1.111 | -1.667 | [0.2 - 2] |
debtRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 0.6] |
interestCoverageTTM | 10.77 | 1.000 | 7.12 | 7.12 | [3 - 30] |
operatingCashFlowPerShareTTM | 6.92 | 2.00 | 7.69 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 6.92 | 2.00 | 6.54 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 2.5] |
grossProfitMarginTTM | 0.464 | 1.000 | 5.60 | 5.60 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.150 | 1.000 | 9.00 | 9.00 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0 | 1.000 | -1.111 | -1.111 | [0.2 - 2] |
assetTurnoverTTM | 0 | 0.800 | -3.33 | -2.67 | [0.5 - 2] |
Total Score | 3.43 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 36.82 | 1.000 | 6.38 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0860 | 2.50 | -0.0997 | -0.233 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 6.92 | 2.00 | 7.69 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0.429 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 6.92 | 2.00 | 7.69 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 1.340 | 1.500 | 4.40 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0834 | 1.000 | -0.415 | 0 | [0.1 - 0.5] |
Total Score | 4.23 |
Shalby Limited
Shalby Limited operates multi-specialty hospitals primarily in India. The company offers arthroscopy, arthroplasty, cardiology, cardiothoracic and vascular surgery, cosmetic and aesthetic, dental cosmetic and implant ology, emergency medicine, endocrinology, endoscopy and laparoscopy, ENT surgery, gastroentero surgery, gastroenterology, general medicine and surgery, hair transplant, liver disease and transplant, and hip and knee joint replacement services. It also provides infectious disease, infertility and IVF, intensive and critical care, maxillofacial surgery, nephrology, neuro surgery, neurology, obesity surgery, obstetrics and gynecology, oncology, oncosurgery, ophthalmology and glaucoma, orthopedic and trauma, pediatric orthopedic, pathology and microbiology, pediatrics and neonatology, plastic surgery, pulmonology and chest, radiology and imaging, rheumatology, trauma, organ donation, and urosurgery services. The company operates 11 hospitals comprising aggregate capacity of 2,012 beds. In addition, it offers outpatient services through 50 outpatient clinics, as well as provides educational programs and fellowships for paramedical students and other healthcare professionals; and homecare health services, such as attendants, doctors, nursing, physiotherapy, pathology, pharmacy, and medical equipment, as well as conducts clinical research trials. It also operates in Kenya, Tanzania, Rwanda, Uganda, the United Arab Emirates, Bangladesh, Cambodia, Jakarta, Oman, Uzbekistan, Nepal, and internationally. The company was formerly known as Shalby Hospitals Limited and changed its name to Shalby Limited in February 2008. Shalby Limited was founded in 1994 and is headquartered in Ahmedabad, India.
Über Live-Signale
Die Live-Signale auf dieser Seite helfen dabei zu bestimmen, wann man NA kaufen oder verkaufen soll. Die Signale haben eine Verzögerung von bis zu 1 Minute; wie bei allen Marktsignalen besteht die Möglichkeit von Fehlern oder Fehleinschätzungen.
Die Live-Handelssignale sind nicht endgültig und getagraph.com übernimmt keine Verantwortung für Maßnahmen, die aufgrund dieser Signale ergriffen werden, wie in den Nutzungsbedingungen beschrieben. Die Signale basieren auf einer breiten Palette von technischen Analyseindikatoren.